<p>医疗人力资源公司 AMN Healthcare Services 将在本周四收盘后公布财报。以下是投资者需要了解的内容。</p>
<p>AMN Healthcare Services 在上个季度超出了分析师的收入预期 2.7%，报告收入为 6.345 亿美元，同比下降 7.7%。这是公司一个非凡的季度，超出了分析师的每股收益预期，并且下个季度的收入指引也超过了分析师的预期。</p>
<p>在财报发布前，AMN Healthcare Services 是买入还是卖出？请阅读我们的完整分析，活跃的 Edge 会员可以免费获取。</p>
<p>本季度，分析师预计 AMN Healthcare Services 的收入将同比下降 1.5%，达到 7.239 亿美元，较去年同期的 10.2% 下降有所改善。调整后的每股收益预计为 0.27 美元。</p>
<p>在过去 30 天内，覆盖该公司的分析师普遍重新确认了他们的预期，表明他们预计公司在财报发布前将保持稳定。AMN Healthcare Services 有超越华尔街预期的历史，在过去两年中每次都超出收入预期，平均超出 2.1%。</p>
<p>观察 AMN Healthcare Services 在医疗服务提供商和服务领域的同行，一些公司已经公布了第四季度的业绩，给我们提供了一些预期的线索。Ensign Group 实现了同比收入增长 25.9%，但未达到分析师的预期，差距为 4.8%；而 DaVita 的收入增长了 9.9%，超出了预期 3.2%。Ensign Group 在业绩公布后上涨了 13.8%，而 DaVita 也上涨了 21.2%。</p>
<p>请在这里阅读我们对 Ensign Group 业绩的完整分析，以及对 DaVita 业绩的分析。</p>
<p>2025 年的前景仍然受到潜在贸易政策变化和企业税务讨论的影响，这可能会影响商业信心和增长。尽管一些医疗服务提供商的股票在这种波动的环境中表现良好，但整体表现不佳，过去一个月股价平均下跌 3.5%。AMN Healthcare Services 在同一时期下跌了 12.4%，并且在财报发布前的平均分析师目标价为 20.86 美元（相比当前股价 16.45 美元）。</p>

<p>AMN Healthcare Services 将于本周四公布其第四季度财报。上个季度，它的收入超出预期 2.7%，报告为 6.345 亿美元，但同比下降了 7.7%。分析师预计本季度收入将下降 1.5%，降至 7.239 亿美元，调整后的每股收益为 0.27 美元。该公司有超出预期的历史，但其股票最近下跌了 12.4%，分析师的平均目标价为 20.86 美元，而当前价格为 16.45 美元</p>

<p>Healthcare staffing company AMN Healthcare Services will be announcing earnings results this Thursday after the bell. Here’s what investors should know.</p>
<div class="lb-trans"><p>医疗人力资源公司 AMN Healthcare Services 将在本周四收盘后公布财报。以下是投资者需要了解的内容。</p>
</div><p>AMN Healthcare Services beat analysts’ revenue expectations by 2.7% last quarter, reporting revenues of $634.5 million, down 7.7% year on year. It was an exceptional quarter for the company, with a beat of analysts’ EPS estimates and revenue guidance for next quarter exceeding analysts’ expectations.</p>
<div class="lb-trans"><p>AMN Healthcare Services 在上个季度超出了分析师的收入预期 2.7%，报告收入为 6.345 亿美元，同比下降 7.7%。这是公司一个非凡的季度，超出了分析师的每股收益预期，并且下个季度的收入指引也超过了分析师的预期。</p>
</div><p>Is AMN Healthcare Services a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.</p>
<div class="lb-trans"><p>在财报发布前，AMN Healthcare Services 是买入还是卖出？请阅读我们的完整分析，活跃的 Edge 会员可以免费获取。</p>
</div><p>This quarter, analysts are expecting AMN Healthcare Services’s revenue to decline 1.5% year on year to $723.9 million, improving from the 10.2% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.27 per share.</p>
<div class="lb-trans"><p>本季度，分析师预计 AMN Healthcare Services 的收入将同比下降 1.5%，达到 7.239 亿美元，较去年同期的 10.2% 下降有所改善。调整后的每股收益预计为 0.27 美元。</p>
</div><p>Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMN Healthcare Services has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 2.1% on average.</p>
<div class="lb-trans"><p>在过去 30 天内，覆盖该公司的分析师普遍重新确认了他们的预期，表明他们预计公司在财报发布前将保持稳定。AMN Healthcare Services 有超越华尔街预期的历史，在过去两年中每次都超出收入预期，平均超出 2.1%。</p>
</div><p>Looking at AMN Healthcare Services’s peers in the healthcare providers &amp; services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. The Ensign Group delivered year-on-year revenue growth of 25.9%, missing analysts’ expectations by 4.8%, and DaVita reported revenues up 9.9%, topping estimates by 3.2%. The Ensign Group traded up 13.8% following the results while DaVita was also up 21.2%.</p>
<div class="lb-trans"><p>观察 AMN Healthcare Services 在医疗服务提供商和服务领域的同行，一些公司已经公布了第四季度的业绩，给我们提供了一些预期的线索。Ensign Group 实现了同比收入增长 25.9%，但未达到分析师的预期，差距为 4.8%；而 DaVita 的收入增长了 9.9%，超出了预期 3.2%。Ensign Group 在业绩公布后上涨了 13.8%，而 DaVita 也上涨了 21.2%。</p>
</div><p>Read our full analysis of The Ensign Group’s results here and DaVita’s results here.</p>
<div class="lb-trans"><p>请在这里阅读我们对 Ensign Group 业绩的完整分析，以及对 DaVita 业绩的分析。</p>
</div><p>The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the healthcare providers &amp; services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.5% on average over the last month. AMN Healthcare Services is down 12.4% during the same time and is heading into earnings with an average analyst price target of $20.86 (compared to the current share price of $16.45).</p>
<div class="lb-trans"><p>2025 年的前景仍然受到潜在贸易政策变化和企业税务讨论的影响，这可能会影响商业信心和增长。尽管一些医疗服务提供商的股票在这种波动的环境中表现良好，但整体表现不佳，过去一个月股价平均下跌 3.5%。AMN Healthcare Services 在同一时期下跌了 12.4%，并且在财报发布前的平均分析师目标价为 20.86 美元（相比当前股价 16.45 美元）。</p>
</div>

AMN Healthcare Services (AMN) 第四季度财报预期